Impact of nirsevimab universal prophylaxis on RSV bronchiolitis hospitalizations. A tertiary level children's hospital perspective
In our population, Nirsevimab prophylaxis was very effective and led to a considerable reduction in the number of infants infected with RSV and requiring hospitalization. The hospital burden of bronchiolitis was significantly reduced.
Authors
- Manola Comar (ORCID: https://orcid.org/0000-0002-9487-861X)
- Silvia Nider
- Carolina Cason (ORCID: https://orcid.org/0000-0002-3456-4395)
- Cristina Zappetti
- Margherita Dal Cin
- Manuela Giangreco (ORCID: https://orcid.org/0000-0002-4479-3087)
- Giorgio Cozzi
- Laura Travan (ORCID: https://orcid.org/0000-0002-8660-8345)
- Stefania Tonetto (ORCID: https://orcid.org/0009-0009-8565-8672)
- Elena Fasiolo
- Alessandro Amaddeo
Institutions
- University of Trieste (IT)
- IRCCS Materno Infantile Burlo Garofolo (IT)
- Directorate of Health (IS)
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
- Regione Autonoma Friuli Venezia Giulia (IT)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2026-02-19
- DOI
- https://doi.org/10.3389/fped.2026.1676689
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00